background

Precision Medicine & Genomics

Dark, high-tech aesthetic - DNA helix with oncology pathway overlays, NGS sequencer, and secure data flow lines to India.

Architecting Predictable Outcomes in India’s Life Science Ecosystem

Precision Medicine & Genomics

As Precision Medicine and Genomics move to the center of global drug development, the complexity of managing distributed R&D increases exponentially. India offers significant advantages in NGS throughput and bioinformatics, yet global innovators face systemic risks in data fidelity, clinical relevance, and regulatory bridging.

Aventiq Bio serves as your Independent Technical Proxy in India. We provide high-level governance for NGS platforms, biomarkers, and Companion Diagnostics (CDx), ensuring that genomics-driven programs are built on audit-ready data and defensible partner intelligence.

  • Conflict-Free Advisory

    We perform no sequencing or bioinformatics. Our neutrality ensures unbiased partner vetting and objective data audits.

  • Precision Oncology Focus

    Specialized governance for patient stratification, oncology biomarkers, and CDx-linked assets.

  • Regulatory Convergence

    Advisory frameworks designed to bridge Indian NGS operations and FDA/EMA/CLIA standards.

about

 

Technical Stewardship Activities (Advisory Only)

The Aventiq Assurance

    FDA/EMA CDx Alignment

    CLIA/CAP Quality Benchmarks

    ALCOA+ Data Standards

    Ironclad IP Firewalls

All engagements are confidential. No information is shared without written consent.